ALS Drug, Riluzole, Being Tested in Alzheimer’s Patients May Work by Protecting Neurons

ALS Drug, Riluzole, Being Tested in Alzheimer’s Patients May Work by Protecting Neurons
Riluzole, a drug approved for the treatment of amyotrophic lateral sclerosis (ALS), might reverse genetic changes often observed in patients with Alzheimer’s disease and age-related cognitive decline. The findings support a clinical trial now exploring if riluzole is beneficial for Alzheimer’s patients. Researchers at Rockefeller University have previously shown that riluzole can prevent memory loss in

Knowledge is power when living with alzheimers.

Get access to the web’s leading Alzheimer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *